squamous cell carcinoma
Palmetto Declines to Cover Molecular Risk Stratification Tests for Cutaneous Squamous Cell Carcinoma
The three other Medicare administrative contractors that participate in the MolDx program aligned their coverage with Palmetto's.
Castle Biosciences Squamous Cell Cancer Test Utility Boosted by New Validation Data, Expert Opinion
Premium
Updated validation data for the DecisionDx-SCC test was published earlier this month, followed by an opinion paper offering consensus guidelines for clinical use.
The company reported that its Barrett's esophagus risk assay saw volumes more than triple in Q3 2023 compared to the same period last year.
Local Coverage Determinations Roundup: Castle Biosciences
Multiple Medicare Administrative Contractors aligned their non-coverage decisions for Castle Biosciences' DecisionDx-SCC test.
DermTech Using $144M Financing to Spur Marketing, Telemedicine Efforts For Molecular Melanoma Assay
Premium
The firm expects to increase commercial coverage for its pigmented lesion assay for melanoma while widening its pipeline to diagnose other varieties of skin cancer.